期刊文献+

鲁西南地区烟雾病临床特点及其外科治疗策略 被引量:9

Clinical characteristics of Moyamoya disease in the southwest of Shandong Province and its surgical treatment strategies
原文传递
导出
摘要 目的探讨鲁西南地区烟雾病临床特点和外科治疗经验。方法对自2011年3月至2013年12月济宁医学院附属医院神经外科收治的96例烟雾病患者临床资料进行回顾性分析。并将分析结果与日韩及国内相关报道分析比较。结果鲁西南地区烟雾病在发病年龄、性别比及临床表现方面具有特殊性,与日韩及国内相关报道不完全一致。具体表现为:女性多于男性(与日韩相似);有0~10岁及3l~50岁2个发病高峰期(与日韩相似);但发病年龄更集中(与国内报道相似1且儿童发病率(12.5%1明显低于日韩;临床表现以缺血型为主(80.2%),但短暂脑缺血发作(TIA)的发生率高f高于日韩及国内报道),癫痫和脑梗死的发生率低(低于日韩及国内报道),脑出血的发生率(19.8%1与日本及国内报道相似,明显低于韩国。经颅内外血管重建术治疗后大部分患者的临床症状得到改善.与日韩及国内相关报道的治疗效果无明显差异。结论鲁西南地区的烟雾病临床特点具有特殊性,其发病机制可能与日韩存在差异;颅内外血管重建术治疗烟雾病临床效果显著,是治疗烟雾病的有效方法。 Objective To explore the clinical characteristics of patients with Moyamoya disease in the southwest of Shandong province and evaluate the efficacy of cerebral revaseularization treatment in it. Methods Clinical data of 96 patients with Moyamoya disease, admitted to our hospital form March 2011 to December 2013, were analyzed retrospectively and compared with those in Japan, South Korea and Inland. Results The clinical characteristics of patients with Moyamoya disease in the southwest of Shandong province were similar with that in Japan, South Korea and Inland, but enjoyed their own particularity: the age distribution showed two peaks (aged 0-10 and aged 31-50) and the sex ratio (female〉male) was similar to those among Japanese and Korean patients, but the age distribution was more concentrated; the incidence of children (12.5%) was significantly lower than that of Japan and South Korea; the main type of Moyamoya disease was the ischemic one (80.2%); the occurrence of transient ischemic attack was higher than that in Japan, South Korea and Inland; the incidences of epilepsy and cerebral infarction were lower than those in Japan, South Korea and Inland; the incidence of cerebral hemorrhage (19.8%) was similar to Japan and Inland, and significantly lower than that in Korea. The clinical symptoms of most Moyamoya disease patients were improved with the treatment of extracranial-intracranial revascularization; and the treatment outcomes showed no significant difference between Chinese, Japanese and Korean. Conclusions The clinical features and pathogenesis mechanism of Moyamoya disease in the southwest of Shandong province may be different form Japan and South Korea. Extracranial-intracranial revascularization is a effective treatment for Moyamoya disease.
出处 《中华神经医学杂志》 CAS CSCD 北大核心 2015年第4期511-515,共5页 Chinese Journal of Neuromedicine
基金 国家自然科学基金(81071779) 山东省中青年科学家科研奖励基金(BS2010YY006)
关键词 脑血管重建术 脑底异常血管网病 外科治疗 Cerebral revascularization Moyamoya disease Surgical treatment
  • 相关文献

参考文献15

  • 1Ahn IM, Park DH, Hann HJ, et al. Incidence, prevalence, and survival of moyamoya disease in Korea: a nationwide, population-based study[J]. Stroke, 2014, 45(4): 1090-1095.
  • 2Duan L, Bao XY, Yang WZ, et al. Moyamoya disease in China: its clinical features and outcomes[J]. Stroke, 2012, 43(1): 56-60.
  • 3段炼,史万超,咸鹏,赵峰,杨伟中,李德生,冯捷,韩聪,宗睿,张正善.成人烟雾病临床特征分析[J].中国卒中杂志,2008,3(7):472-476. 被引量:24
  • 4Ikezaki K, Han DH, Kawano T, et al. A clinical comparison of definite moyamoya disease between South Korea and Japan [J]. Stroke, 1997, 28(12): 2513-2517.
  • 5靳峰,冯嵩,张浩,韩光魁,郭强,王嵘,张东.颅内外血管重建术治疗烟雾病[J].中华神经外科杂志,2014,30(2):125-128. 被引量:18
  • 6Amin-Hanjani S, Barker FG, Charbel F, et al. Extracranial-intracranial bypass for stoke-is this the end of the line or a bump in the road? [J]. Neurosurgery, 2012, 71(3): 557-561.
  • 7Amin-Hanjani S, Singh A, Rifai H, et al. Combined direct and indirect bypass for moyamoya: quantitative assessment of direct bypass flow over time[J]. Neurosurgery, 2013, 73(6): 962-967.
  • 8Mukerji N, Steinberg GK. Burr holes for Moyamoya[J]. World Neurosurg, 2014, 81 ( 1 ): 29-31.
  • 9Kim DS, Huh PW, Kim I-IS, et al. Surgical treatment ofmoyamoya disease in adults: combined direct and indirect vs. indirect bypass surgery[J]. Neurol Med Chir (Tokyo), 2012, 52(5): 333-338.
  • 10Kronenburg A, Braun KP, van der Zwan A, et al. Recent advances in moyamoya disease: pathophysiology and treatment [J]. Curr Neurol Neurosci Rep, 2014, 14(1): 423.

二级参考文献48

  • 1陈诤,毛颖,周良辅.烟雾病的研究进展[J].国外医学(脑血管疾病分册),2004,12(10):761-764. 被引量:40
  • 2段炼,孙伟建,王芙昱,李生,杨伟中,孔繁文.国人烟雾病临床特征探讨[J].中国临床神经外科杂志,2005,10(4):269-271. 被引量:75
  • 3高山,倪俊,黄家星,黄一宁,汪波.烟雾病临床特点分析[J].中华神经科杂志,2006,39(3):176-179. 被引量:98
  • 4[1]Suzuki J,Takaku A.Cerebrovascular "moyamoya" disease:diseaseshowing abnormal net-like vessels in base of brain[J].Arch Neurol,1969,20:288-299.
  • 5[2]Yonekawa Y,Ogata N,Kaku Y,et al.Moyamoya disease in Europe,past and present status[J].Clin Neurol Neurosurg,1997,99(suppl 2):s58-60.
  • 6[3]Chiu D,Shedden P,Bratina P,et al.Clinical features of moyamoya disease in the United States[J].Stroke,1998,29:1347-1351.
  • 7[4]Ikezaki K,Han DH,Kawano T,et al.Clinical comparison of definite moyamoya diseases between South Korea and Japan[J].Stroke 1997,28:2513-2517.
  • 8[5]Suzuki J,Kodama N.Moyamoya disease:a review[J].Stroke,1983,14:104-109.
  • 9[6]Ikezaki K,Han DH,Kawano T,et al.A clinicalcomparison of definite moyamoya disease between South Korea andJapan[J].Stroke,1997,28:2513-2517.
  • 10[9]Sakurai K,Horiuchi Y,Ikeda H,et al.A novel susceptibility locus for moyamoya disease on chromosome 8q23[J].J Hum Genet,2004,49:278-281.

共引文献44

同被引文献74

  • 1蒋森,夏成雨,傅先明.安徽地区单中心烟雾病临床特征特点分析[J].立体定向和功能性神经外科杂志,2019,0(6):366-370. 被引量:1
  • 2段炼,史万超,咸鹏,赵峰,杨伟中,李德生,冯捷,韩聪,宗睿,张正善.成人烟雾病临床特征分析[J].中国卒中杂志,2008,3(7):472-476. 被引量:24
  • 3段炼,孙伟建,王芙昱,李生,杨伟中,孔繁文.国人烟雾病临床特征探讨[J].中国临床神经外科杂志,2005,10(4):269-271. 被引量:75
  • 4PARK EK, LEE YH, SHIM KW, et al. Nature history and progression factors of unilateral moyamoya disease in pediatric patients [J].Childs Nerv Syst, 2011,27(8) : 1281-1287.
  • 5BABA T, HOUKIN K, KURODA S. Novel epidemiological features of moyamoya disease [J]. J Neurol Neurnsurg Psychiatry, 2008,79 ( 8 ) : 900-904.
  • 6ARIAS EJ, DERDEYN CP, DACEY RG Jr, et al. Advances and surgical considerations in the treatment of moyamoya disease [J ]. Neurosurgery, 2014,74 ( 1 ) : S116-S125.
  • 7LIU X, ZHANG D, SHUO W, et al. Long term outcome after conservative and surgical treatment of haemorrhagic moyamoya disease [J].J Neurol Neurosury Psychiatry, 2013,84 (3) : 258- 265.
  • 8KRONENBURG A, BRAUN KP, VAN DER ZWAN A,et al. Recent advances in moyamoya disease: pathophysiology and treatment [J]. Curr Neurol Neurosci Rep, 2014,14 (1) :423 - 431.
  • 9ANIN-HANJANI S, BARKER FG , CHARBEL FT, et al. Extracranial intraeranial bypass for stroke-is this the end of the line or a bump in the road? [J].Ncurosurgery,2012,71 (3): 557-561.
  • 10SU SH, HAI J, ZHANG L, et al. Quality of life and psychological impact in adult patients with hemorrhagic moyamoya disease who received no surgical revascularization [ J ]. J Neurol Sci, 2013, 328(1-2) : 32-36.

引证文献9

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部